CAT No: CP27279
CAS No:62084-21-3
Synonyms/Alias:Nalpha-Boc-biocytin;62062-43-5;Nalpha-Boc-Nepsilon-biotinyl-L-lysine;Nepsilon-Biotinyl-Nalpha-Boc-L-lysine;N-t-Boc-biocytin;N|A-Boc-Biocytin;15083_ALDRICH;N-BoC-N'-Biotinyl-L-lysine;15083_FLUKA;CTK8G2058;MolPort-003-926-637;ZINC15721447;FT-0663475;(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydrothieno[3,4-d]imidazolidin-4-yl]pentanamido}-2-[(tert-butoxycarbonyl)amino]hexanoicacid;N2-(tert-Butyloxycarbonyl)-N6-[5-[[(3aS)-2-oxo-2,3,3abeta,4,6,6abeta-hexahydro-1H-thieno[3,4-d]imidazole]-4alpha-yl]pentanoyl]-L-lysine
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.